Literature DB >> 21233208

Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus.

I-Ju Liu1, Chien-Yu Chiu, Yun-Ching Chen, Han-Chung Wu.   

Abstract

The pathogenesis of dengue hemorrhagic fever and dengue shock syndrome (DHF/DSS), both serious complications of dengue virus (DV) infection, remains unclear. In this study, we found that anti-DV NS1 (nonstructural protein 1) polyclonal antibodies cross-reacted with human umbilical vein endothelial cells (HUVECs). We further identified a complex-specific mAb, DB16-1, which could recognize DV NS1 and cross-react with HUVECs and human blood vessels. The target protein of DB16-1 was further purified by immunoaffinity chromatography. LC-MS/MS analysis and co-immunoprecipitation revealed that the target protein of DB16-1 was human LYRIC (lysine-rich CEACAM1 co-isolated). Our newly generated anti-LYRIC mAbs bound to HUVECs in a pattern similar to that of DB16-1. The B-cell epitope of DB16-1 displayed a consensus motif, Lys-X-Trp-Gly (KXWG), which corresponded to amino acid residues 116-119 of DV NS1 and mimicked amino acid residues 334-337 in LYRIC. Moreover, the binding activity of DB16-1 in NS1 of DV-2 and in LYRIC disappeared after the KXWG epitope was deleted in each. In conclusion, DB16-1 targeted the same epitope in DV NS1 and LYRIC protein on human endothelial cells, suggesting that it might play a role in the pathogenesis of DHF/DSS. Future studies on the role of the anti-NS1 antibody in causing vascular permeability will undoubtedly be performed on sera collected from individuals before, during, and after the endothelial cell malfunction phase of a dengue illness.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21233208      PMCID: PMC3058979          DOI: 10.1074/jbc.M110.170993

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Infection of human cells by dengue virus is modulated by different cell types and viral strains.

Authors:  M S Diamond; D Edgil; T G Roberts; B Lu; E Harris
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 2.  Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever.

Authors:  Joshua Fink; Feng Gu; Subhash G Vasudevan
Journal:  Rev Med Virol       Date:  2006 Jul-Aug       Impact factor: 6.989

3.  Complement dependent cytotoxicity (CDC) activity of a humanized anti Lewis-Y antibody: FACS-based assay versus the 'classical' radioactive method -- qualification, comparison and application of the FACS-based approach.

Authors:  A Nechansky; O H J Szolar; P Siegl; I Zinoecker; N Halanek; S Wiederkum; R Kircheis
Journal:  J Pharm Biomed Anal       Date:  2009-02-04       Impact factor: 3.935

4.  Identification of B-cell epitope of dengue virus type 1 and its application in diagnosis of patients.

Authors:  H C Wu; Y L Huang; T T Chao; J T Jan; J L Huang; H Y Chiang; C C King; M F Shaio
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

5.  Antibodies from dengue patient sera cross-react with endothelial cells and induce damage.

Authors:  Chiou-Feng Lin; Huan-Yao Lei; Ai-Li Shiau; Ching-Chuan Liu; Hsiao-Sheng Liu; Trai-Ming Yeh; Shun-Hua Chen; Yee-Shin Lin
Journal:  J Med Virol       Date:  2003-01       Impact factor: 2.327

6.  Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells.

Authors:  C Lunardi; C Bason; R Navone; E Millo; G Damonte; R Corrocher; A Puccetti
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

7.  Glucocorticoids and rituximab in vitro: synergistic direct antiproliferative and apoptotic effects.

Authors:  Andrea L Rose; Barbara E Smith; David G Maloney
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

8.  Generation and characterization of monoclonal antibodies against dengue virus type 1 for epitope mapping and serological detection by epitope-based peptide antigens.

Authors:  Yun-Ching Chen; Hsien-Neng Huang; Chin-Tarng Lin; Yi-Fang Chen; Chwan-Chuen King; Han-Chung Wu
Journal:  Clin Vaccine Immunol       Date:  2007-02-07

9.  Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery.

Authors:  Tong-Young Lee; Chin-Tarng Lin; Szu-Yao Kuo; De-Kuan Chang; Han-Chung Wu
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

10.  Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide.

Authors:  Chiou-Feng Lin; Huan-Yao Lei; Ai-Li Shiau; Hsiao-Sheng Liu; Trai-Ming Yeh; Shun-Hua Chen; Ching-Chuan Liu; Shu-Chen Chiu; Yee-Shin Lin
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

View more
  50 in total

Review 1.  The role of AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system disease.

Authors:  Evan K Noch; Kamel Khalili
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

Review 2.  Endothelial cells in dengue hemorrhagic fever.

Authors:  Anon Srikiatkhachorn; James F Kelley
Journal:  Antiviral Res       Date:  2014-07-12       Impact factor: 5.970

3.  Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system.

Authors:  David L Akey; W Clay Brown; Somnath Dutta; Jamie Konwerski; Joyce Jose; Thomas J Jurkiw; James DelProposto; Craig M Ogata; Georgios Skiniotis; Richard J Kuhn; Janet L Smith
Journal:  Science       Date:  2014-02-06       Impact factor: 47.728

4.  Predicting Zika virus structural biology: Challenges and opportunities for intervention.

Authors:  Bryan D Cox; Richard A Stanton; Raymond F Schinazi
Journal:  Antivir Chem Chemother       Date:  2016-06-13

5.  Correlation between serum levels of anti-endothelial cell autoantigen and anti-dengue virus nonstructural protein 1 antibodies in dengue patients.

Authors:  Hsien-Jen Cheng; Yueh-Hsia Luo; Shu-Wen Wan; Chiou-Feng Lin; Shan-Tair Wang; Nguyen Thanh Hung; Ching-Chuan Liu; Tzong-Shiann Ho; Hsiao-Sheng Liu; Trai-Ming Yeh; Yee-Shin Lin
Journal:  Am J Trop Med Hyg       Date:  2015-03-09       Impact factor: 2.345

Review 6.  Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology.

Authors:  Lucile Warter; Ramapraba Appanna; Katja Fink
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

7.  A highly conserved region between amino acids 221 and 266 of dengue virus non-structural protein 1 is a major epitope region in infected patients.

Authors:  Magot Diata Omokoko; Sabar Pambudi; Supranee Phanthanawiboon; Promsin Masrinoul; Chayanee Setthapramote; Tadahiro Sasaki; Motoki Kuhara; Pongrama Ramasoota; Akifumi Yamashita; Itaru Hirai; Kazuyoshi Ikuta; Takeshi Kurosu
Journal:  Am J Trop Med Hyg       Date:  2014-04-28       Impact factor: 2.345

Review 8.  Myasthenia gravis and infectious disease.

Authors:  Nils Erik Gilhus; Fredrik Romi; Yu Hong; Geir Olve Skeie
Journal:  J Neurol       Date:  2018-01-25       Impact factor: 4.849

9.  Dengue virus NS1 enhances viral replication and pro-inflammatory cytokine production in human dendritic cells.

Authors:  Farah Alayli; Frank Scholle
Journal:  Virology       Date:  2016-06-24       Impact factor: 3.616

Review 10.  Astrocyte elevated gene-1 (AEG-1) and the A(E)Ging HIV/AIDS-HAND.

Authors:  Neha Vartak-Sharma; Shruthi Nooka; Anuja Ghorpade
Journal:  Prog Neurobiol       Date:  2016-04-14       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.